Adam Friedman, MD, FAAD: Expert Insights and Advice on Navigating AAD
Along with his session insights on diet and chronic spontaneous urticaria, Friedman shares tips for navigating the largest dermatology conference in the US.
Information on TikTok About Spironolactone is Unreliable, New Study Finds
The top videos under the hashtag, #spironolactone” had low scores on the mDISCERN and GQS scales, according to Adam Friedman, MD, FAAD, senior author of the study.
The Skin Smart Campus Initiative: Promoting Skin Health and Public Awareness at GW
George Washington University recently earned a Skin Smart Campus designation, championing skin cancer prevention through education, free sunscreen, and UV safety measures.
Pearls for Treatment Selection and Managing Adverse Effects in Hyperhidrosis
Personalized care is key to managing hyperhidrosis, blending therapies, addressing adverse effects, and empowering patients with tailored solutions.
Exploring Oral Therapies for Hyperhidrosis: Current and Future Perspectives
Adam Friedman, MD, FAAD, takes a closer look at the emerging landscape of oral treatments for hyperhidrosis and what lies ahead in advancing patient care.
Adam Friedman, MD, FAAD: Exploring the Utilization of Immunomodulators as Therapeutic Interventions in Chronic Spontaneous Urticaria
In addition to recapping key highlights from his session, Friedman discusses what is new or upcoming in dermatology that most excites him.
Grant Program Accepting Applications, Seeks to Bridge Care Gap in Inflammatory Dermatoses
Grant applications are open from now until August 24, 2023, with an anticipated project start/end date of January 2024 through July 2025.
Top 5 Articles of the Week: April 13-18
Dermatology Times' Sunday Crossword: April 20, 2025
The Weekly Roundup: April 14-18
The Rx Recap: April 13-19